Hims Hers Health

Hims Hers Health

Yahoo Finance • 3 days ago

1 Healthcare Stock Worth Your Attention and 2 We Turn Down

1 Healthcare Stock Worth Your Attention and 2 We Turn Down From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong fin... Full story

Yahoo Finance • 7 days ago

Most shorted stocks on Wall Street

[short sale] abluecup As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of shares outstan... Full story

Yahoo Finance • 17 days ago

2 Reasons to Like HIMS (and 1 Not So Much)

2 Reasons to Like HIMS (and 1 Not So Much) The past six months have been a windfall for Hims & Hers Health's shareholders. The company's stock price has jumped 40.2%, hitting $29.23 per share. This was partly due to its solid quarterly re... Full story

Yahoo Finance • 21 days ago

Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges

Key Points Interested in Quest Diagnostics Incorporated? Here are five stocks we like better. Quest Diagnostics is outperforming its growth targets: Revenue increased about 12% and earnings more than 10% in 2025, while 2026 guidance calls... Full story

Yahoo Finance • 23 days ago

Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares

Chief Legal Officer Soleil Boughton reported a sale of 6,236 shares of Hims & Hers Health (NYSE:HIMS) in a recent SEC Form 4 filing. Transaction summary Metric Value Shares sold 6,236 Transaction value $173,735 Post-transaction shares (d... Full story

Yahoo Finance • last month

Catalyst Watch: FOMC blockbuster, Salesforce event, and 24-hour trading talk

[Reciprocal Tariffs] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - SEPTEMBER 14 * VOLATILIT... Full story

Yahoo Finance • last month

JPMorgan cautious on Hims & Hers on GLP-1 transition risk

Investing.com -- JPMorgan revealed Friday that it has started coverage of Hims & Hers Health at Neutral, setting a December 2027 price target of $32 as it weighs the direct-to-consumer health platform's rapid growth against execution risks... Full story

Yahoo Finance • last month

Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report?

A month has gone by since the last earnings report for Hims & Hers Health, Inc. (HIMS). Shares have lost about 7.7% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend contin... Full story

Yahoo Finance • last month

HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss

Hims & Hers Health, Inc. HIMS delivered second-quarter 2026 revenue of $753.2 million, up 38.2% year over year and 9.1% above the Zacks Consensus Estimate. Subscriber growth and higher spending per subscriber kept the top line moving highe... Full story

Yahoo Finance • last month

Reasons to Retain Hims & Hers Stock in Your Portfolio for Now

Hims & Hers Health HIMS has entered the second half of 2026 with strong momentum from weight-loss offerings, international expansion and AI-enabled care. However, gross-margin pressure from changing business mix, regulatory uncertainty sur... Full story

Yahoo Finance • last month

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

Collaboration aims to validate Evotec's proprietary BiTco costimulatory CD2 bispecifics platform in combination with Plectonic's logic-gated DNA-protein immunotherapy technology LOGIBODY® BiTco designed to boost T cell activation by engagi... Full story

Yahoo Finance • last month

Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key

Hims & Hers Health, Inc. (NYSE:HIMS) has entered Australia, marking its first expansion into the Asia-Pacific market. The move follows its acquisition of Australian digital-health platform Eucalyptus, which includes men's health brand Pilo... Full story

Yahoo Finance • last month

Trending stocks this week as big tech reports quarterly numbers

Wall Street ended the week in the green, as investors digested blockbuster Nvidia (NVDA [https://seekingalpha.com/symbol/NVDA]) earnings, policy signals from the Jackson Hole symposium, and the latest U.S. GDP print. On the economic data f... Full story

Yahoo Finance • last month

Hims & Hers Health (HIMS) Is Down 14.6% After Raising Guidance Amid Privacy Scrutiny - What's Changed

Earlier this week, Hims & Hers Health reported quarterly revenue of US$753.2 million, up 38.2% year on year, added 307,000 customers to reach 2.89 million, and raised both next-quarter revenue guidance and full-year EBITDA guidance above a... Full story

Yahoo Finance • last month

Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company

On August 18, 2026, Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum told CNBC that a Federal Trade Commission lawsuit over the company's data-sharing and subscription practices "misunderstands how the company works." He defended the... Full story

Yahoo Finance • last month

Hims & Hers (HIMS)’ Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes

On August 21, 2026, Bloomberg reported that Hims & Hers Health, Inc. (NYSE:HIMS) was enrolled in Visa Inc. (NYSE:V)'s Acquirer Monitoring Program after customer credit card disputes in its weight-loss subscription business exceeded accepta... Full story

Yahoo Finance • 2 months ago

Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group

Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group Check out the companies making headlines yesterday: Funko (NASDAQ:FNKO): Pop culture collectibles manufacturer Funko (NASDAQ:FNKO) rose by 4.9%... Full story

Yahoo Finance • 2 months ago

4 stocks to watch on Tuesday: META, DKS, JNJ, and HIMS

[Currency trader on video call from his home office] Alistair Berg Stock index futures were higher on Tuesday as traders geared up for Nvidia results and inflation data set to land on Wednesday. Here are four stocks to watch on the day:... Full story

Yahoo Finance • 2 months ago

Hims & Hers Shares Tumble on Visa Dispute Crackdown

This article first appeared on GuruFocus. Hims & Hers Health (NYSE:HIMS) shares dipped about 8% Monday after reports that Visa had placed the telehealth company under a monitoring program tied to customer payment disputes. The action fol... Full story

Yahoo Finance • 2 months ago

Why Hims & Hers Health (HIMS) Stock Is Nosediving

Why Hims & Hers Health (HIMS) Stock Is Nosediving What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 9.2% in the afternoon session after Bloomberg reported that Visa enrolled the telehealth company in its Acq... Full story